Paraneoplastic Systemic Lupus Erythematosus in Papillary Thyroid Carcinoma: A Rare Case of Autoimmune-malignancy Interplay

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by multisystem involvement.Its association with malignancies, particularly thyroid carcinoma, is rare but clinically significant.We report a unique case of paraneoplastic SLE in a 48-year-old female with a history of papillary thyroid carcinoma.The patient presented with fever, weight loss, joint pain, and skin manifestations, including a malar rash and oral ulcers.Laboratory findings revealed pancytopenia, proteinuria, positive antinuclear antibodies (ANA), and anti-TPO antibodies, leading to a diagnosis of SLE.Imaging studies demonstrated hypermetabolic lymphadenopathy and residual thyroid activity.Immunosuppressive therapy with methylprednisolone and hydroxychloroquine was initiated, and a total thyroidectomy was performed to address the underlying malignancy.The patient showed significant clinical improvement, with resolution of pancytopenia, fever, and skin lesions.This case highlights the complex interplay between autoimmunity and malignancy, emphasizing the importance of early recognition, a multidisciplinary approach, and tailored therapeutic strategies.Further research is needed to elucidate the mechanisms linking SLE and thyroid cancer and to optimize management protocols for such rare cases.

Authors

Publication Details

Journal
Bengal Physician Journal
Published
2026-02-18
DOI
https://doi.org/10.5005/jp-journals-10070-8107
Primary Topic
Autoimmune Neurological Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Paraneoplastic Systemic Lupus Erythematosus in Papillary Thyroid Carcinoma: A Rare Case of Autoimmune-malignancy Interplay

Arbind Kumar Chaudhary, Anamitra Hait
Bengal Physician Journal
Autoimmune Neurological Disorders and Treatments
article

Paraneoplastic Systemic Lupus Erythematosus in Papillary Thyroid Carcinoma: A Rare Case of Autoimmune-malignancy Interplay

Arbind Kumar Chaudhary, Anamitra Hait
article en

Abstract

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by multisystem involvement.Its association with malignancies, particularly thyroid carcinoma, is rare but clinically significant.We report a unique case of paraneoplastic SLE in a 48-year-old female with a history of papillary thyroid carcinoma.The patient presented with fever, weight loss, joint pain, and skin manifestations, including a malar rash and oral ulcers.Laboratory findings revealed pancytopenia, proteinuria, positive antinuclear antibodies (ANA), and anti-TPO antibodies, leading to a diagnosis of SLE.Imaging studies demonstrated hypermetabolic lymphadenopathy and residual thyroid activity.Immunosuppressive therapy with methylprednisolone and hydroxychloroquine was initiated, and a total thyroidectomy was performed to address the underlying malignancy.The patient showed significant clinical improvement, with resolution of pancytopenia, fever, and skin lesions.This case highlights the complex interplay between autoimmunity and malignancy, emphasizing the importance of early recognition, a multidisciplinary approach, and tailored therapeutic strategies.Further research is needed to elucidate the mechanisms linking SLE and thyroid cancer and to optimize management protocols for such rare cases.

Bengal Physician JournalVol. 13(1)
Good health and well-being
Openalex Percentile: Top 53%
Autoimmune Neurological Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.